Received May 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 5P4A5 | LA |
has administered Expired Arexvy vaccine to 2 patients; This non-serious case was reported by a pharmacist via sales rep and described the occurrence of expired vaccine used in a male patient who received RSVPreF3 adjuvanted (Arexvy) (batch number 5P4A5, expiry date 27-MAR-2025) for prophylaxis. On 21-MAY-2025, the patient received the 1st dose of Arexvy (left arm). On 21-MAY-2025, an unknown time after receiving Arexvy, the patient experienced expired vaccine used (Verbatim: has administered Expired Arexvy vaccine to 2 patients). The outcome of the expired vaccine used was not applicable. Additional Information: GSK receipt date: 21-MAY-2025 The reporter reported that the patient had received expired Arexvy vaccine which led to, expired vaccine used. As it was administered to 2 patients, there were 2 initials by pharmacist as they was husband and wife. This case had been link with US2025063393, reported by the same reporter.; Sender's Comments: US-GSK-US2025063393:Female patient